Lung Cancer Specialist

Hear directly from medical experts who specialize in lung cancer.

Lung cancer is the third most diagnosed cancer in the U.S. and the leading cause of cancer death each year. There are two main types called non-small cell lung cancer (NSCLC) and small cell lung cancer. There is a push to ensure patients get genomic or biomarker testing done to determine whether they have a targetable mutation. If there is, there are often more treatment options available.

Explore interviews with medical experts who specialize in breast cancer, including oncologists, nurses, medical staff, and social workers. They share the kind of conversations you can turn to them to have - from new treatment options to navigating the day-to-day life with lung cancer.

Oncologists

Dr. Ross Camidge discusses ALK lung cancer treatments and side effects
Learn how to manage ALK+ lung cancer treatment side effects, when to call your care team, and why dose adjustments can help you stay on therapy longer. Featuring D. Ross Camidge, MD, PhD
Jill Feldman interviews Dr. Eric Singhi about Lung Cancer Comprehensive biomarker testing to guide lung cancer treatment
The science is clear: knowing what is driving your specific lung cancer before you start treatment can change everything about the care you receive. This program will explain why comprehensive biomarker testing is the foundation of the right treatment plan.
The Patient Exchange - Improving Diversity in Clinical Trials

The Patient Exchange: Improving Diversity in Clinical Trials



Take part in a transformative conversation with five Black patients as they share their journeys navigating clinical trials.
NSCLC Biomarkers Jill Feldman and Dr. Lovly Interview

Understanding Biomarkers in Lung Cancer



Lung cancer patient and advocate Jill Feldman sits down with Dr. Christine Lovly, one of the top lung cancer specialists in the U.S., to ask the questions she believes will help change lives.